In a major development that helps ease tension in the country's anti-Covid vaccination campaign, results from the much-awaited U.S. trial of the Oxford-AstraZeneca vaccine confirmed that it is both safe and highly effective.
"The AstraZeneca US Phase III trial of AZD1222 demonstrated statistically significant vaccine efficacy of 79% at preventing symptomatic COVID-19 and 100% efficacy at preventing severe disease and hospitalisation," the UK-based pharmaceutical and biotechnology giant said in a statement.
Subscribe to continue reading the article.
This article is part of our premium content offering.Subscribe with a RTTNews subscription.
Subscribe NowAlready subscribed? Sign in
For comments and feedback: editorial@rttnews.com